FGF21 Enhances Therapeutic Efficacy and Reduces Side Effects of Dexamethasone in Treatment of Rheumatoid Arthritis
Authors (first, second and last of 11)
Inflammation presents the latest international advances in experimental and clinical research on the physiology, biochemistry, cell biology, and pharmacology of inflammation. Published items include full-length scientific reports, short definitive articles, and papers from meetings and symposia proceedings. The journal's coverage extends to acute and chronic inflammation; mediators of inflammation; mechanisms of tissue injury and cytotoxicity; pharmacology of inflammation; and clinical studies of inflammation and its modification.
Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.
- Reports on the latest international advances in understanding and treating inflammation
- Covers acute and chronic inflammation, pharmacology, cytotoxicology and among other topics
- Offers papers, short articles, proceedings and more
- 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Bruce N Cronstein
- Publishing model
- Hybrid. Learn about publishing OA with us
Journal metrics
- 3.212 (2019)
- Impact factor
- 3.062 (2019)
- Five year impact factor
- 26 days
- Submission to first decision
- 103 days
- Submission to acceptance
- 191,489 (2019)
- Downloads
Latest issue
Latest articles
-
-
-
Surfactant Attenuates Air Embolism-Induced Lung Injury by Suppressing NKCC1 Expression and NF-κB Activation
Authors (first, second and last of 5)
-
Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell
Authors (first, second and last of 17)
-
Down–regulating miR-217-5p Protects Cardiomyocytes against Ischemia/Reperfusion Injury by Restoring Mitochondrial Function via Targeting SIRT1
Authors (first, second and last of 4)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
About this journal
- Electronic ISSN
- 1573-2576
- Print ISSN
- 0360-3997
- Abstracted and indexed in
-
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- EMBiology
- Elsevier Biobase
- Google Scholar
- Highbeam
- IFIS Publishing
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Oncogenes and Growth Factors Abstracts
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Virology and AIDS Abstracts
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature
